Literature DB >> 12098716

Tamoxifen may increase risk of uterine sarcoma.

Scott Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12098716      PMCID： PMC1123584          DOI： 10.1136/bmj.325.7354.7/a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Treatment of pure uterine sarcoma at the Institut Català D'Oncologia.

Authors:  Gonçalo Fernandez; Susanna Marín I Borràs; Valentín Navarro Pérez; Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2013-01-16

2.  DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Aleksandra Czerw
Journal:  Onco Targets Ther       Date:  2017-09-14       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.